SF3B1 and myeloproliferative disorder: The specific mutation sites of SF3B1 in our study were mainly distributed at the 700th, 666th, 625th, and 662nd amino acid sites, which was similar to the findings of other studies on RARS-T or MDS/MPN-RS-T [9–11].